Polysaccharide Bioinks for 3D Bioprinting: A Guide to Translation
Polysaccharides · 28.10.2026 · 7 (4) · 121
DOI: 10.3390/polysaccharides7040121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polysaccharides, online erschienen am 28.10.2026. Verfasst von Adrian Bibis und 4 weiteren Autor:innen. Die Arbeit nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian Ministry of Research, Innovation and Digitalization, European Regional Development Fund, Research Institute of the University of Bucharest.
Abstract (Originalsprache)
Polysaccharide-based hydrogels offer versatile platforms for three-dimensional bioprinting, but translation requires coordinated assessment of formulation, processing, and biological performance. This narrative review connects backbone chemistry and functionalization with rheology, crosslinking, printing modality, cellular responses, and manufacturing requirements. It examines alginate, hyaluronic acid, chitosan, cellulose derivatives, gellan gum, and complementary polysaccharides, distinguishing cell-laden bioinks from acellular biomaterial inks and supporting materials. A study-specific framework separates material feasibility, cell-laden printing, functional in vitro outcomes, preclinical evaluation, and preliminary human feasibility without assigning maturity scores to entire material families. Print fidelity and cellular remodeling impose competing requirements whose balance is formulation- and application-dependent. Dual or sequential crosslinking, dynamic networks, and support-bath printing provide complementary approaches rather than a universal solution. Inconsistent reporting limits cross-study comparison; a minimum reporting set is therefore proposed. Sterilization, raw-material variability, quality control, long-term safety, and regulatory classification are considered alongside formulation design. Future priorities include tissue-appropriate viscoelasticity, granular architectures, hierarchical vascularization, and reproducible data-driven optimization. Clinical translation will require stronger links between manufacturing reproducibility and sustained biological function, rather than printing accuracy alone.
Förderung
- Romanian Ministry of Research, Innovation and Digitalization
- European Regional Development Fund
- Research Institute of the University of Bucharest
Zitieren
APA
Bibis, A., Paraschiv, A., Batalu, N. D., Visan, A. I., & Cristescu, R. (2026). Polysaccharide Bioinks for 3D Bioprinting: A Guide to Translation. Polysaccharides, 7(4), 121. https://doi.org/10.3390/polysaccharides7040121
Vancouver
Bibis A, Paraschiv A, Batalu ND, Visan AI, Cristescu R. Polysaccharide Bioinks for 3D Bioprinting: A Guide to Translation. Polysaccharides. 2026;7(4):121. doi:10.3390/polysaccharides7040121
BibTeX
@article{Bibis2026,
author = {Bibis, Adrian and Paraschiv, Alexandru and Batalu, Nicolae Dan and Visan, Anita Ioana and Cristescu, Rodica},
title = {Polysaccharide Bioinks for 3D Bioprinting: A Guide to Translation},
journal = {Polysaccharides},
year = {2026},
volume = {7},
number = {4},
pages = {121},
doi = {10.3390/polysaccharides7040121}
}
EUVIMED